Thousands of families in the US have been struggling with a shortage of infant formula for over half a year, with attempts to resolve the situation undermined by industry interests
During the Covid-19 pandemic, Pfizer has used every opportunity to maximize its profits, even if this meant reduced access to life-saving medical products for most of the world. The same is about to happen in the case of Paxlovid, the company’s Covid-19 oral treatment
While a public desperate for protection against COVID-19 is quick to shame “vaccine hunters,” the real culprits are the companies refusing to share their publicly funded intellectual property and the governments allowing them to get away with it.
The situation is such that the public sector, long maligned by neoliberal economists and weakened by governments beholden to neoliberalism, is playing a major role in the fight against coronavirus